Asymchem Laboratories (Tianjin) Co., Ltd.
002821
Rankning i aktier
#2511
Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development... Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development and manufacturing organization (CDMO), offering its expertise to pharmaceutical and biotechnology companies both globally and within Mainland China. Their services encompass drug research, development, and production, supporting projects across the entire drug lifecycle, from early clinical phases to commercial scale. This includes R&D and cGMP-compliant manufacturing of advanced intermediates, active pharmaceutical ingredients (APIs), and finished drug formulations, in addition to providing clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the distribution (wholesale, retail, and direct sale) of medicines, and initiatives focused on advancing pharmaceutical science and technology. The company, established in 1999, maintains its headquarters in Tianjin, China.
Aktiekurs
$20.91
Marknadsvärde
$7.57B
Förändring (1 dag)
-8.26%
Förändring (1 år)
41.25%
Land
CN
Handel Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Kategori
Healthcare
Antal utestående aktier för Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Antal utestående aktier per June 2026: 356.25M
Enligt de senaste finansiella rapporterna och aktiekursen för Asymchem Laboratories (Tianjin) Co., Ltd. är det aktuella antalet utestående aktier 356.25M. I slutet av December 2024 hade företaget 352.77M utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Asymchem Laboratories (Tianjin) Co., Ltd. (002821) från 2011 till 2026
Utestående aktier vid slutet av varje år
| År | Utestående aktier | Ändra |
|---|---|---|
| 2026 (TTM) | 356.25M | -0.60% |
| 2025 | 358.41M | 1.60% |
| 2024 | 352.77M | -2.67% |
| 2023 | 362.43M | -0.98% |
| 2022 | 366.03M | 7.77% |
| 2021 | 339.64M | 4.15% |
| 2020 | 326.11M | 1.78% |
| 2019 | 320.42M | 0.46% |
| 2018 | 318.94M | 0.80% |
| 2017 | 316.43M | 23.41% |
| 2016 | 256.40M | 1.98% |
| 2015 | 251.42M | -0.31% |
| 2014 | 252.21M | 0.04% |
| 2013 | 252.10M | 0.13% |
| 2012 | 251.78M | 0.41% |
| 2011 | 250.74M | 0.00% |
Utestående aktier för liknande företag eller konkurrenter
| Företag | Utestående aktier | Skillnad | Land |
|---|---|---|---|
| 253.90M | -28.73% |
US
|
|
| 396.00M | 11.16% |
US
|
|
| 478.91M | 34.43% |
AU
|
|
| 0.00 | -100.00% |
BE
|
|
| 62.19M | -82.54% |
NL
|
